CONTINUUS Pharmaceuticals

CONTINUUS Pharmaceuticals | 1,828 followers on LinkedIn | End-to-end Integrated Continuous Manufacturing of pharmaceuticals: novel process technologies to enable rapid production | CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. In achieving this goal, we look to radically transform the pharmaceutical manufacturing industry, steering it away from outdated batch systems to state-of-the-art continuous processes. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT.